Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Imdelltra

(im-DEL-trah)
A drug used to treat adults with extensive-stage small cell lung cancer that got worse during or after treatment with platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Imdelltra binds to a protein called CD3, which is found on T cells (a type of white blood cell). It also binds to a protein called DLL3, which is found on some types of cancer cells. This may help the immune system kill cancer cells. Imdelltra is a type of bispecific T-cell engager. Also called tarlatamab.
More Information
Search NCI's Dictionary of Cancer Terms